期刊
BLOOD
卷 117, 期 3, 页码 857-861出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2010-09-307041
关键词
-
类别
资金
- Ministerio de Ciencia e Innovacion [SAF2007-61 814]
- Marie Curie Training Network, European Union [MRTN-CT-2005-019284]
- Instituto de Salud Carlos III
- Associazione Italiana per la Ricerca sul Cancro, Istituto Superiore di Sanita [40G.41]
- Ministero della Salute
- Juan de la Cierva Program
- Departament d'Universitats, Recerca i Societat de la Informacio (Generalitat de Catalunya)
Levels of regulatory T cells (Tregs) are increased in different cancer types as well as in inflammatory diseases, such as rheumatoid arthritis. Treg accumulation may result from aberrant proliferation and trafficking as well as greater resilience to oxidative stress compared with conventional T cells. This enhanced antioxidative capacity of Tregs possibly serves as feedback inhibition during inflammation and prevents uncontrolled immune reactions by favoring survival of suppressor rather than effector cells. In this study, we demonstrate that human Tregs express and secrete higher levels of thioredoxin-1, a major antioxidative molecule. Thioredoxin-1 has an essential role in maintaining their surface thiol density as the first line of antioxidative defense mechanisms and is sensitive to proinflammatory stimuli, mainly tumor necrosis factor-alpha, in a nuclear factor-kappa B-dependent fashion. The antiapoptotic and oncogenic potential of (secreted) Trx-1 suggests that it may exert effects in Tregs beyond redox regulation. (Blood.2011;117(3):857-861)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据